Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea- induced mammary tumorigenesis in rats

Nutrition and Cancer

Volumn 35, Issue 1, 1999, Pages 50-57

  Rickard, Sharon E ^a   Yuan, Yvonne V ^a   Chen, Jianmin ^a   Thompson, Lilian U ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; LIGNAN; METHYLNITROSOUREA; SECOISOLARICIRESINOL DIGLYCOSIDE; SOYBEAN OIL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; FEMALE; FLAX; NONHUMAN; RAT; TUMOR VOLUME;

EID: 0032806446     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S1532791450-57     Document Type: Article

References (52)

1. Axelson, M, and Setchell, KD: The excretion of lignans in rats - evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 123, 337-342, 1981.
2. Borriello, SP, Setchell, KD, Axelson, M, and Lawson, AM: Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 58, 37-43, 1985.
3. Setchell, KD, Lawson, AM, Borriello, SP, Harkness, R, Gordon, H, et al.: Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet 2, 4-7, 1981.
4. Mousavi, Y, and Adlercreutz, H: Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 41, 615-619, 1992.
5. Hirano, T, Fukuoka, K, Oka, K, Naito, T, Hosaka, K, et al.: Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1. Cancer Invest 8, 595-602, 1990.
6. Wang, C, and Kurzer, MS: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28, 236-247, 1997.
7. Fotsis, T, Pepper, M, Adlercreutz, H, Fleischmann, G, Hase, T, et al.: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90, 2690-2694, 1993.
8. Adlercreutz, H, Mousavi, Y, Clark, J, Hockerstedt, K, Hamalainen, E, et al.: Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 41, 331-337, 1992.
9. Garreau, B, Vallette, G, Adlercreutz, H, Wahala, K, Makela, T, et al.: Phytoestrogens: new ligands for rat and human α-fetoprotein. Biochim Biophys Acta 1094, 339-345, 1991.
10. Adlercreutz, H, Bannwart, C, Wahala, K, Makela, T, Brunow, G, et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147-153, 1993.
11. Wang, C, Makela, T, Hase, T, Adlercreutz, H, and Kurzer, MS: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 50, 205-212, 1994.
12. Adlercreutz, H, Fotsis, T, Bannwart, C, Hamalainen, E, Bloigu, S, et al.: Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. Steroid Biochem 24, 289-296, 1986.
13. Adlercreutz, H, Fotsis, T, Bannwart, C, Wahala, K, Makela, T, et al.: Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens in urine of women on various habitual diets. J Steroid Biochem 25, 791-797, 1986.
14. Ingram, D, Sanders, K, Kolybaba, M, and Lopez, D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994, 1997.
15. Drill, VA, Martin, DP, Hart, ER, and McConnell, RG: Effect of oral contraceptives on the mammary glands of rhesus monkeys: a prelimi-nary report. JNCI 52, 1655-1657, 1974.
16. Pfeiffer, CA, and Allen, E: Attempts to produce cancer in rhesus monkeys with carcinogenic hydrocarbons and estrogens. Cancer Res 8, 97-127, 1948.
17. Geschickter, CF, and Hartman, CG: Mammary response to prolonged estrogenic stimulation in the monkey. Cancer 12, 767-781, 1959.
18. Adlercreutz, H, Musey, PI, Fotsis, T, Bannwart, C, Wahala, K, et al.: Identification of lignans and phytoestrogens in urine of chimpanzees. Clin Chim Acta 158, 147-154, 1986.
19. Musey, PI, Adlercreutz, H, Gould, KG, Collins, DC, Fotsis, T, et al.: Effect of diet on lignans and isoflavonoid phytoestrogens in chimpanzees. Life Sci 57, 655-664, 1995.
20. Thompson, LU, Robb, P, Serraino, M, and Cheung, F: Mammalian lignan production from various foods. Nutr Cancer 16, 43-52, 1991.
21. Axelson, M. Sjovall, J, Gustafsson, BE, and Setchell, KD: Origin of lignans in mammals and identification of a precursor from plants. Nature 298, 659-660, 1982.
22. Serraino, M, and Thompson, LU: The effect of flaxseed supplementation on the intiation and promotional stages of mammary tumorigenesis. Nutr Cancer 17, 153-159, 1992.
23. Thompson, LU, Rickard, SE, Orcheson, LJ, and Seidl, MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373-1376, 1996.
24. Thompson, LU, Seidl, M, Rickard, S, Orcheson, L, and Fong, H: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165, 1996.
25. Fritsche, KL, and Johnston, PV: Effect of dietary α-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas. J Nutr 120, 1601-1609, 1990.
26. Gullino, PM, Pettigrew, HM, and Grantham, FH: N-nitrosomethylurea as mammary gland carcinogen in rats. JNCI 54, 401-409, 1975.
27. Canadian Council on Animal Care. Guide to the Care and Use of Experimental Animals. Ottawa, ON, Canada: Canadian Council on Animal Care, 1984.
28. Reeves, PG, Nielsen, FH, and Fahey, GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
29. Obermeyer, WR, Musser, SM, Betz, JM, Casey, RE, Pohland, AE, et al.: Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 208, 6-12, 1995.
30. Geran, RI, Greenberg, NH, Macdonald, MM, Schumacher, AM, and Abbott, BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 3, 51-52, 1972.
31. Armitage, P: Tests for linear trends in proportions and frequencies. Biometrics 11, 375-386, 1955.
32. Constantinou, AI, Mehta, RG, and Vaughan, A: Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16, 3293-3298, 1996.
33. Le, CT: Applied Survival Analysis. New York: Wiley, 1997.
34. Adlercreutz, H, Fotsis, T, Watanabe, S, Lampe, J, Wahala, K, et al.: Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev 18, 259-271, 1994.
35. Hislop, TG, Band, PR, Deschamps, M, Ng, V, Coldman, AJ, et al.: Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131, 263-270, 1990.
36. Boyd, NF, Greenberg, C. Lockwood, G, Little, L, Martin, L, et al.: Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. JNCI 89, 488-496, 1997.
37. Rickard, SE, and Thompson, LU: Beneficial health effects and utilization of flaxseed mucilage and lignans. Inform 8, 860-865, 1997.
38. Rogers, AE, and Lee, SY: Chemically-induced mammary gland tumors in rats: modulation by dietary fat. In Dietary Fat and Cancer, C Ip, DF Birt, AE Rogers, and C Mettlin (eds). New York: Liss. 1986, pp 255-282.
39. Cohen, LA, Choi, K, Numoto, S, Reddy, M, Berke, B, et al.: Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet. JNCI 76, 721-730, 1986.
40. Cohen, LA, Polansky, M, Furuya, K, Reddy, M, Berke, B, et al.: Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): interrelationships among BHT concentration, carcinogen dose, and diet JNCI 72, 165-174, 1984.
41. Bien, JG, Stoewsand, GS, Briggs, GM, Phillips, RW, Woodward, JC, et al.: Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 107, 1340-1348, 1977.
42. US Department of Health, Education, and Welfare: Guidelines for Carcinogen Bioassay of Small Rodents. Washington, DC: US Government Printing Office, 1976.
43. Murphy, PA, Farmakalidis, E, and Johnson, LD.: Isoflavone content of soya-based laboratory animal diets. Food Chem Toxicol 20, 315-317, 1982.
44. Boettger-Tong, H, Murthy, L, Chiappetta, C, Kirkland, JL, Goodwin, B, et al.: A case of laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect 106, 369-373, 1998.
45. Thigpen, JE, Setchell, KDR, Goelz, NW, and Forsythe, DB: The phytoestrogen content of rodent diets. Environ Health Perspect 107, A182-A183, 1999.
46. Coert, A, Vonk Noordegraaf, CA, Groen, MB, and Van der Vies, J: The dietary origin of the urinary lignan HPMF. Experientia 38, 904-905, 1982.
47. Lamartiniere, CA, Murrill, WB, Manzolillo, PA, Zhang, JX, Barnes, S, et al.: Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc Soc Exp Biol Med 217, 358-364, 1998.
48. Hirose, M, Masuda, A, Ito, N, Kamano, K, and Okayama, H: Effects of dietary perilla oil, soybean oil and safflower oil on 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethylhydrazine (DMH)-induced mammary gland and colon carcinogenesis in female SD rats. Carcinogenesis 11, 731-735, 1990.
49. Munoz, SF, Silva, RA, Lamarque, A, Guzman, CA, and Eynard, AR: Protective capability of dietary Zizyphus mistol seed oil, rich in 18:3, n-3, on the development of two murine mammary gland adenocarcinomas with high or low metastatic potential. Prostaglandins Leukot Essent Fatty Acids 53, 135-138, 1995.
50. Chajes, V, Sattler, W, Stranzl, A, and Kostner, GM: Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin E. Breast Cancer Res Treat 34, 199-212, 1995.
51. Grammatikos, SI, Subbaiah, PV, Victor, TA, and Miller, WM: n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer 70, 219-227, 1994.
52. Noguchi, M, Rose, DP, Earashi, M, and Miyazaki, I: The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 52, 265-271, 1995.